Inhibition of calcium ATPase by phencyclidine in rat brain

Molecular and Cellular Biochemistry

Volumn 194, Issue 1-2, 1999, Pages 173-177

  Pande, M ^a   Cameron, J A ^b   Vig, P J S ^a   Ali, S F ^c   Desaiah, D ^a,d  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Jackson State University   (United States)

^c NCTR   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

ATPase; Calcium; Central nervous system; In vitro; In vivo; Inhibition; Phencyclidine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; PHENCYCLIDINE; PHOSPHATE; PSYCHEDELIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; MALE; NEUROTOXICITY; NONHUMAN; RAT; SYNAPTIC MEMBRANE;

ANIMALS; BRAIN; CALCIUM-TRANSPORTING ATPASES; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0033057052     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006911420745     Document Type: Article

References (33)

1. Aniline O, Simpson GM: Psychiatric aspects of phencyclidine. In: L. Manzo (ed). Advances In Neurotoxicology. Pergman Press, New York, 1979, pp 27-30
2. Albuquerque EX, Aguayo LG, Warnick JE, Weinstein H, Glick SD, Maayani S, Ickowicz RK, Blaustein MP: The behavioral effects of phencyclidines may be due to their blockade of potassium channels. Proc Natl Acad Sci USA 78: 7792-7796, 1981
3. Ffrench-Mullen JMH, Rogawski MA: Phencyclidine block of calcium current in isolated guinea pig hippocampal neurons. J Physiol 456: 85-105, 1992
4. Tourneur Y, Romey G, Lazdunski M: Phencyclidine blockade of sodium and potassium channels in neuroblastoma cells. Brain Res 5: 154-158, 1982
5. Mattson MP, Rychlik B, Cheng B: Degenerative and axon outgrowth - altering effects of phencyclidine in human fetal cerebral cortical cells. Neuropharmacol 51: 279-291, 1992
6. Mattson MP, Rychlik B, You JS, Sisken JE: Sensitivity of cultured human embryonic cerebral cortical neurons to excitatory amino acid-induced calcium influx and neurotoxicity. Brain Res 542: 97-106, 1991
7. Vincent JP, Cavey D, Kamenka JM, Geneste P, Lazdinski M: Interaction of phencyclidine with the muscarinic and opiate receptors in the central nervous system. Brain Res 152: 176-182, 1978
8. Leonard BE, Tonge SR: Some effect of a hallucinogenic drug (Phencyclidine). Life Sci 9: 1141-1152, 1970
9. Domino EF, Wilson AE: Psychotropic drug influences on brain acetylcholine utilization. Psychopharmacol 25: 291-298, 1972
10. 3H]phencyclidine interactions with the nicotonic acetylcholine receptor channel and its inhibition by psychotripic, antipsychotic, opiate, antidepressant, antibiotic and viral and antiarrythmic drugs. Mol Pharmacol 22: 72-81, 1982
11. Haring R, Kloog Y , Sodolovsky M: Localization of phencyclidine binding sites on alpha and beta subunits of the nicotonic acetylcholine receptor from Torpedo ocellata electric organ using azido phencyclidine. J Neurochem 4: 627-637, 1984
12. Quirion R, Bayorh MA, Zerbe RL, Pert CB: Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain. Pharmacol Biochem Behav 17: 699-702, 1982
13. Gao XM, Tamminga CA: Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48 h time course. Synapse 23: 274-279, 1996
14. Debonnel G, deMontigny C: Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders. Life Sci 58: 721-734, 1996
15. Itoh Y, Oishi R, Nishibori M, Saeki K: Phencyclidine and the dynamics of mouse brain histamine. J Pharmacol Exp Ther 235: 788-792, 1985
16. Nabeshima T, Sivam SP, Norris JC, Ho IK: Calcium-dependent GABA release from mouse brain slices following acute and chronic phencyclidine administration. Res Comm Subst Abuse 2: 343-354, 1981
17. 3H] dopamine from chopped striatal tissue. Neuropharmacol 21: 639-645, 1982
18. Nabeshima T, Yamaguchi K, Hiramatsu M, Amano M, Pumkawa I, Kanneyama T: Serotonergic involvement in phencyclidine-induced behaviors. Pharmacol Biochem Behav 21: 401-408, 1984
19. Bowyer JR, Spuhler KP, Weiner N: Effects of phencyclidine, amphetamine and related compounds in dopamine release from striatal slices. J Pharmacol Exp Ther 257: 262-270, 1984
20. Ali SF, Holson RR, Newport ED, Slikker W Jr, Bowyer JF: Development of dopamine and N-methyl-D-aspartate systems in rat brain: The effect of prenatal phencyclidine exposure. Dev Brain Res 73: 25-33, 1993
21. Corso TD, Sesma MA, Tenkova TI, Der TC, Wozniak DF, Farber NB, Olney JW: Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res 752: 1-14, 1997
22. Rasmussen H, Barrett PG: Calcium messenger system: An integrated view. Physiol Rev 64: 938-984, 1984
23. Komulainen H, Bondy SC: Modulation of levels of free calcium within synaptosomes by organochlorine insecticides. J Pharmacol Exp Ther 241: 575-581, 1987
24. Carafoli E: Intracellular calcium homeostasis. Ann Rev Biochem 56: 395-433, 1987
25. Kodavanti PRS, Pentyala SN, Yallapragada PR, Desaiah D: Amiodarone and desethylamiodarone increase intrasynaptosomal free calcium through receptor mediated channel. Arch Pharmacol 345: 213-221, 1992
26. Enna SJ, Snyder SH: Influence of ions, enzymes, and detergents on γ-amiobutyric acid receptor binding in synaptic membranes of rat brain. Mol Pharmacol 13: 442-453, 1977
27. Yallagragada PR, Vig PJS, Desaiah D: Differential effects of triorganotins on calmodulin activity. J Toxicol Env Health 29: 317-327, 1990
28. Lowry OH, Lopez JA: The determination of inorganic phosphate in the presence of labile phosphate esters. J Biol Chem 162: 421-424, 1946
29. Cooper JE, Cummings AJ, Jones H: The placental transfer of phencyclidine in the pig: Plasma levels in the sow and its piglets. J Physiol 267: 17-26, 1977
30. Strauss A, Modanlou HD, Bosu SK: Neonatal manifestations of maternal phencyclidine abuse. Pediatrics 68: 550-552, 1981
31. Ahmad G, Halsall LC, Bondy SC: Persistence of phencyclidine in fetal brain. Brain Res 415: 194-196, 1987
32. Sircar R, Li CS: PCP/NMDA receptor-channel complex and brain development. Neurotoxicol Teratol 16: 369-375, 1994
33. Sircar R, Follesa P, Ticku MK: Postnatal phencyclidine treatment differentially regulates N-methyl-D-Aspartate receptor subunit mRNA expression in developing rat cerebral cortex. Mol Brain Res 40: 214-220, 1996